1-4 of 4
Xiaoqiu Li
Close
Sort by
Journal Articles

A Phase II Study of Chidamide Plus R-GDP Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Ineligible for Autologous Transplantation: Efficacy and Safety Analysis

Guangliang Chen, Kai Xue, Qunling Zhang, Jia Jin, Yizhen Liu, Zuguang Xia, Fangfang Lyu, Xiaonan Hong, Xiaoqiu LI, Junning Cao
Journal: Blood
Blood (2023) 142 (Supplement 1): 5805.
https://doi.org/10.1182/blood-2023-174307
Published: 2023
Journal Articles

Preliminary Result of Lenalidomide Combined with R-CHOP(R2-CHOP) in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma: A Prospective Phase II Clinical Trial

Yizhen Liu, Qunling Zhang, Fangfang Lv, Xiaojian Liu, Dongmei Ji, Zuguang Xia, Jia Jin, Rong TAO, Wenhao Zhang, Xiaoqiu Li, Shengjian Zhang, Jiachen Wang, Xiaonan Hong, Junning Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 6627–6628.
https://doi.org/10.1182/blood-2022-158657
Published: 2022
Journal Articles

Subtyping Diffuse Large B-Cell Lymphoma with Cell-of-Origin Using 32-Gene Expression Assay in Formalin-Fixed Paraffin-Embedded Tissue

Xiangnan Jiang, MD, Wanhui Yan, Yifeng Sun, Qinghua Xu, Xiaoyan Zhou, MD, Junning Cao, Xiaonan Hong, Xiaoqiu Li
Journal: Blood
Blood (2019) 134 (Supplement_1): 5337.
https://doi.org/10.1182/blood-2019-126629
Published: 2019
Journal Articles

PET-CT Invisible Diffuse Large B-Cell Lymphoma Features a Silent B-Cell Receptor Signaling

Dong Sheng, MD, Ting Li, MD, Xiangnan Jiang, MD, Weige Wang, MD, Y. Lynn Wang, MD PhD, Xiaoqiu Li
Journal: Blood
Blood (2017) 130 (Supplement 1): 2853.
https://doi.org/10.1182/blood.V130.Suppl_1.2853.2853
Published: 2017